A U.S. investigation into the lack of write-downs at Exxon Mobil Corp. despite the slump in oil-prices has brought to light the challenge of assessing impairments under U.S. Generally Accepted Accounting Principles (GAAP). But, for international companies and U.S. firms with foreign operations, figuring out GAAP is not the only contest. For the Wall Street Journal’s CFO Journal, I have taken a closer look at write-downs under GAAP vs. IFRS.
Yuan’s Reserve Currency Status No Game Changer for Companies, WSJ
Deutsche Bank, E.ON Fuel Spike in German Goodwill Impairments, WSJ
Figuring out GAAP is not the only challenge, WSJ
Bayer’s diligence failure haunts its Monsanto purchase, WSJ
Bayer AG’s failure to identify weaknesses in Merck & Co.’s over the counter drug business before it bought it in 2014 sets a problematic precedent for its latest acquisition, an M&A expert told me today. Why? Read my piece for the Wall Street Journal’s CFO Journal.
New Rolls-Royce CFO Faces tricky accounting, WSJ
Pile of debts awaits new Anglo American CFO, WSJ
After Paying Off Debt, Lanxess will take on more, WSJ
Bayer moving out its comfort zone with Monsanto bid, WSJ
75 % debt financing, a rights issue plus a potential downgrade: In my first story for the Wall Street Journal’s CFO Journal, I take a closer look at why Bayer’s financing for the Monsanto takeover marks a departure from its typical, conservative approach to acquisition funding.
European Corporate Investment May Lag Despite ECB Bond Buying, WSJ
The ECB today decided to keep interest rates and its asset purchasing program unchanged. For the Wall Street Journal’s CFO Journal, I have spoken to companies about what the ECB’s corporate bond buying means for them – and their appetite for M&A, share buy-backs and further expansion.